← Leaderboards
Seulki Lee
Johns Hopkins University
$718,471
Attributed
$718,471
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2013–15$250K$187.5K$125K$62.5K$0
'13
'14
'15
Funding mix
By agency
NIH$718,471 · 1
By mechanism
R00$718,471 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Zaver M Bhujwalla$35,375,851
- Martin G Pomper$38,517,075
- Peter B Barker$12,208,416
- Anirban Maitra$50,247,714
- Marc M Greenberg$18,493,458
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsAntibodiesAnti-Cancer TherapeuticAntitumor AgentApoptosisApoptoticBaseCaspaseCellsChemical StructureChemistryClinical ApplicationCombination Drug TherapyCostCost EffectiveDesignDetectionDiagnostic ImagingDoseDrug CandidateDrug DiscoveryDrug EfficacyDrug TargetingAnimal Model
Grant awards (3)
Development of preclinical HTS for discovery of drugs modulating apoptosis$235,094
R00 · FY2015 · EB · contact PI
Development of preclinical HTS for discovery of drugs modulating apoptosis$234,377
R00 · FY2014 · EB · contact PI
Development of preclinical HTS for discovery of drugs modulating apoptosis$249,000
R00 · FY2013 · EB · contact PI